These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
460 related articles for article (PubMed ID: 18194120)
1. Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: a prospective, randomized, controlled study. Nematalla AH; Bakr MA; Gheith OA; Elagroudy AE; Elshahawy el-M; Aghoneim M Exp Clin Transplant; 2007 Dec; 5(2):673-9. PubMed ID: 18194120 [TBL] [Abstract][Full Text] [Related]
2. Steroid avoidance reduce the cost of morbidities after live-donor renal allotransplants: a prospective, randomized, controlled study. Gheith OA; Nematalla AH; Bakr MA; Refaie A; Shokeir AA; Ghoneim MA Exp Clin Transplant; 2011 Apr; 9(2):121-7. PubMed ID: 21453230 [TBL] [Abstract][Full Text] [Related]
3. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960 [TBL] [Abstract][Full Text] [Related]
4. A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial. Ishida H; Takahara S; Amada N; Tomikawa S; Chikaraishi T; Takahashi K; Uchida K; Akiyama T; Tanabe K; Toma H; Exp Clin Transplant; 2016 Oct; 14(5):518-525. PubMed ID: 27733107 [TBL] [Abstract][Full Text] [Related]
5. Cost-benefit of steroid avoidance in renal transplant patients: a prospective randomized study. Gheith OA; Nematalla AH; Bakr MA; Refaie A; Shokeir AA; Ghoneim MA Scand J Urol Nephrol; 2010 Apr; 44(3):175-82. PubMed ID: 20230185 [TBL] [Abstract][Full Text] [Related]
6. Quadruple immunosuppression with basiliximab, tacrolimus, mycophenolate mofetil and prednisone is safe and effective for renal transplantation. Miura M; Harada H; Fukuzawa N; Iwami D; Taniguchi A; Seki T; Togashi M; Ogawa Y; Satoh H; Hirano T Clin Transplant; 2005; 19 Suppl 14():54-8. PubMed ID: 15955170 [TBL] [Abstract][Full Text] [Related]
7. Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen. Yang SL; Wang D; Wu WZ; Lin WH; Xu TZ; Cai JQ; Tan JM Transpl Immunol; 2008 Jan; 18(3):281-5. PubMed ID: 18047938 [TBL] [Abstract][Full Text] [Related]
9. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient. Montini G; Murer L; Ghio L; Pietrobon B; Ginevri F; Ferraresso M; Cardillo M; Scalamogna M; Perfumo F; Edefonti A; Zanon GF; Zacchello G Transpl Int; 2005 Jan; 18(1):36-42. PubMed ID: 15612981 [TBL] [Abstract][Full Text] [Related]
10. Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients. Oberholzer J; John E; Lumpaopong A; Testa G; Sankary HN; Briars L; Kraft KA; Knight PS; Verghese P; Benedetti E Pediatr Transplant; 2005 Aug; 9(4):456-63. PubMed ID: 16048597 [TBL] [Abstract][Full Text] [Related]
11. Thymoglobulin induction in liver transplant recipients with a tacrolimus, mycophenolate mofetil, and steroid immunosuppressive regimen: a five-year randomized prospective study. Boillot O; Seket B; Dumortier J; Pittau G; Boucaud C; Bouffard Y; Scoazec JY Liver Transpl; 2009 Nov; 15(11):1426-34. PubMed ID: 19877264 [TBL] [Abstract][Full Text] [Related]
12. [Early steroid withdrawal in pediatric renal transplantation]. Delucchi B A; Valenzuela A M; Ferrario B M; Lillo D AM; Guerrero G JL; Rodríguez S E; Cano Sch F; Cavada Ch G; Godoy L J; Rodríguez H J; González G G; Buckel B E; Contreras M L Rev Med Chil; 2006 Nov; 134(11):1393-401. PubMed ID: 17277852 [TBL] [Abstract][Full Text] [Related]
13. Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months. Ramirez CB; Doria C; di Francesco F; Iaria M; Kang Y; Marino IR J Surg Res; 2007 Apr; 138(2):198-204. PubMed ID: 17292404 [TBL] [Abstract][Full Text] [Related]
14. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients. Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352 [TBL] [Abstract][Full Text] [Related]
15. A prospective randomized open study in liver transplant recipients: daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids. Otero A; Varo E; de Urbina JO; Martín-Vivaldi R; Cuervas-Mons V; González-Pinto I; Rimola A; Bernardos A; Otero S; Maldonado J; Herrero JI; Barrao E; Domínguez-Granados R Liver Transpl; 2009 Nov; 15(11):1542-52. PubMed ID: 19877219 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage. Liu CL; Fan ST; Lo CM; Chan SC; Ng IO; Lai CL; Wong J Liver Transpl; 2004 Jun; 10(6):728-33. PubMed ID: 15162466 [TBL] [Abstract][Full Text] [Related]
17. Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation. Lo A; Stratta RJ; Alloway RR; Egidi MF; Shokouh-Amiri MH; Grewal HP; Gaber LW; Gaber AO Transpl Int; 2001 Dec; 14(6):396-404. PubMed ID: 11793037 [TBL] [Abstract][Full Text] [Related]
18. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Chhabra D; Skaro AI; Leventhal JR; Dalal P; Shah G; Wang E; Gallon L Clin J Am Soc Nephrol; 2012 Mar; 7(3):504-12. PubMed ID: 22282478 [TBL] [Abstract][Full Text] [Related]
19. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance. Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971 [TBL] [Abstract][Full Text] [Related]
20. Early steroid withdrawal in adult kidney transplantation at a single center. Iwamoto H; Hama K; Konno O; Yokoyama T; Kihara Y; Jojima Y; Nakamura Y; Takeuchi H; Shimazu M Transplant Proc; 2012 Jan; 44(1):179-81. PubMed ID: 22310609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]